Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: A reproducible predictor of outcome?

Anderson, J, Gordon, T, McManus, A, Mapp, T, Gould, S, Kelsey, A, McDowell, H, Pinkerton, R, Shipley, J and Pritchard-Jones, K (2001) Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: A reproducible predictor of outcome?. British Journal of Cancer, 85 6: 831-835. doi:10.1054/bjoc.2001.2008


Author Anderson, J
Gordon, T
McManus, A
Mapp, T
Gould, S
Kelsey, A
McDowell, H
Pinkerton, R
Shipley, J
Pritchard-Jones, K
Title Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: A reproducible predictor of outcome?
Journal name British Journal of Cancer   Check publisher's open access policy
ISSN 0007-0920
Publication date 2001-09-14
Sub-type Article (original research)
DOI 10.1054/bjoc.2001.2008
Volume 85
Issue 6
Start page 831
End page 835
Total pages 5
Language eng
Subject 1306 Cancer Research
2730 Oncology
Abstract Rhabdomyosarcoma has 2 major histological subtypes, embryonal and alveolar. Alveolar histology is associated with the fusion genes PAX3-FKHR and PAX7-FKHR. Definition of alveolar has been complicated by changes in terminology and subjectivity. It is currently unclear whether adverse clinical behaviour is better predicted by the presence of these fusion genes or by alveolar histology. We have determined the presence of the PAX3/7-FKHR fusion genes in 91 primary rhabdomyosarcoma tumours using a combination of classical cytogenetics, FISH and RT-PCR, with a view to determining the clinical characteristics of tumours with and without the characteristic translocations. There were 37 patients with t(2;13)/PAX3-FKHR, 8 with t(1;13) PAX7-FKHR and 46 with neither translocation. One or other of the characteristic translocations was found in 31/38 (82%) of alveolar cases. Univariate survival analysis revealed the presence of the translocation t(2;13)/PAX3-FKHR to be an adverse prognostic factor. With the difficulties in morphological diagnosis of alveolar rhabdomyosarcoma on increasingly used small needle biopsy specimens, these data suggest that molecular analysis for PAX3-FKHR will be a clinically useful tool in treatment stratification in the future. This hypothesis requires testing in a prospective study. Variant t(1;13)/PAX7-FKHR appears biologically different, occurring in younger patients with more localised disease.
Keyword Prognosis
Rhabdomyosarcoma
Translocation
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Article (original research)
Collections: ResearcherID Downloads
Scopus Import
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 63 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 74 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Sat, 09 Jul 2016, 03:46:43 EST by System User